PCI Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about PCI clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Not Applicable

ELEVATE High-Risk PCI Pivotal Study

High-Risk Percutaneous Coronary Intervention (High-risk PCI)
Magenta Medical Ltd.290 enrolled28 locationsNCT07001332
Recruiting
Not Applicable

Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions

Coronary Arterial Disease (CAD)PCICalcified Coronary Lesions
Nanjing First Hospital, Nanjing Medical University78 enrolled3 locationsNCT07093788
Recruiting
Phase 4

Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)

Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
J.P.S Henriques300 enrolled1 locationNCT06916520
Recruiting
Not Applicable

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Acute Myocardial InfarctionPercutaneous Coronary Intervention (PCI)
Instituto de Investigación Sanitaria y Biomédica de Alicante132 enrolled2 locationsNCT06788275
Recruiting
Not Applicable

Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures

High-risk PCICoronary Artery Disease Risk High
Amsterdam UMC, location VUmc98 enrolled8 locationsNCT07380217
Recruiting
Not Applicable

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial

ST-elevation Myocardial Infarction (STEMI)Primary PCI
Chen Jing6,294 enrolled1 locationNCT07361783
Recruiting

The 3D Stent Study

Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)
CoreAalst BV200 enrolled4 locationsNCT06898021
Recruiting

Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR

In-stent RestenosisPCIIntravascular Imaging Device
Nanjing First Hospital, Nanjing Medical University1,500 enrolled1 locationNCT07297641
Recruiting
Phase 4

Effect of Empagliflozin on Inflammation

InflamationCAD - Coronary Artery DiseasePCI+1 more
Hotel Dieu de France Hospital100 enrolled1 locationNCT07292909
Recruiting
Not Applicable

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients

Diabetes MellitusHypertensionHyperlipidemia+2 more
China National Center for Cardiovascular Diseases536 enrolled1 locationNCT06615609
Recruiting

Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons

Percutaneous Coronary Intervention (PCI)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3,000 enrolled1 locationNCT07231835
Recruiting
Phase 4

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
University of Florida40 enrolled1 locationNCT07025148
Recruiting

Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction

Coronary Arterial Disease (CAD)Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Azienda Ospedaliera di Bolzano1,500 enrolled1 locationNCT06910436
Recruiting
Not Applicable

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

ECMOHigh-risk PCI
Beijing Anzhen Hospital176 enrolled1 locationNCT06274411
Recruiting
Not Applicable

Interventional Left Ventricular Assist System for PCI in CHIP Patients

High-Risk Percutaneous Coronary Intervention (High-risk PCI)Left Ventricular Assist Devices
Suzhou Hengruihongyuan Medical Technology Co. LTD286 enrolled15 locationsNCT07053618
Recruiting
Not Applicable

Medipixel XA-Assisted PCI in Coronary Artery Disease

Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
CHA University830 enrolled6 locationsNCT06985693
Recruiting

Double Kissing-crush vs Controlled Balloon-crush Techniques For Complex Coronary Bfurcation Lesions

Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)Bifurcation Coronary Disease
Istanbul Mehmet Akif Ersoy Educational and Training Hospital300 enrolled2 locationsNCT06931574
Recruiting
Not Applicable

Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention

Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)Ischemia, Myocardial
Odense University Hospital3,150 enrolled3 locationsNCT06692140
Recruiting
Phase 4

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Atrial Fibrillation (AF)Percutaneous Coronary Intervention (PCI)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern3,010 enrolled15 locationsNCT05955365
Recruiting
Phase 3

Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Jiangsu vcare pharmaceutical technology co., LTD1,000 enrolled1 locationNCT06577519